|
1
|
MPM BioImpact
Boston,
Massachusetts
|
$25.3M
|
–
|
–
|
–
|
|
|
2
|
New Leaf Venture Partners
New York
|
$24.9M
|
–
|
–
|
–
|
|
|
3
|
MPM Asset Management
Boston,
Massachusetts
|
$24.7M
|
+$11.3K
|
+112
|
+0%
|
|
|
4
|
|
$20.6M
|
–
|
–
|
–
|
|
|
5
|
|
$13.7M
|
+$200K
|
+1,988
|
+1%
|
|
|
6
|
Vanguard Group
Malvern,
Pennsylvania
|
$10.2M
|
+$305K
|
+3,033
|
+2%
|
|
|
7
|
Avidity Partners Management
Dallas,
Texas
|
$9.41M
|
-$3.11M
|
-30,940
|
-21%
|
|
|
8
|
Franklin Resources
San Mateo,
California
|
$8.94M
|
-$57.9K
|
-576
|
-0.5%
|
|
|
9
|
|
$7.9M
|
–
|
–
|
–
|
|
|
10
|
Millennium Management
New York
|
$4.76M
|
+$5.93M
|
+58,959
|
+4,480%
|
|
|
11
|
Cormorant Asset Management
Boston,
Massachusetts
|
$4.27M
|
–
|
–
|
–
|
|
|
12
|
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$3.87M
|
–
|
–
|
–
|
|
|
13
|
Nantahala Capital Management
New Canaan,
Connecticut
|
$3.31M
|
-$249K
|
-2,477
|
-6%
|
|
|
14
|
Two Sigma Investments
New York
|
$3.21M
|
+$4.09M
|
+40,647
|
New
|
|
|
15
|
Renaissance Technologies
New York
|
$3.17M
|
+$4.03M
|
+40,079
|
New
|
|
|
16
|
State Street
Boston,
Massachusetts
|
$3.03M
|
-$9.5M
|
-94,465
|
-71%
|
|
|
17
|
Geode Capital Management
Boston,
Massachusetts
|
$3M
|
+$284K
|
+2,825
|
+8%
|
|
|
18
|
Two Sigma Advisers
New York
|
$2.98M
|
+$3.79M
|
+37,750
|
New
|
|
|
19
|
Laurion Capital Management
New York
|
$2.42M
|
-$3.26M
|
-32,462
|
-51%
|
|
|
20
|
Affinity Asset Advisors
New York
|
$1.98M
|
+$2.01M
|
+20,000
|
+400%
|
|
|
21
|
Marshall Wace North America
New York
|
$1.8M
|
–
|
–
|
–
|
|
|
22
|
International Biotechnology Trust
London,
United Kingdom
|
$1.7M
|
+$2.16M
|
+21,500
|
New
|
|
|
23
|
|
$1.69M
|
-$141K
|
-1,403
|
-6%
|
|
|
24
|
Northern Trust
Chicago,
Illinois
|
$1.56M
|
-$114K
|
-1,131
|
-5%
|
|
|
25
|
Federated Hermes
Pittsburgh,
Pennsylvania
|
$1.01M
|
-$2.31K
|
-23
|
-0.2%
|
|
